Heragen, Inc. is developing a novel genomic based Breast Cancer Recurrence Test. Heragen, Inc. will help physicians and oncologists make educated decisions using a patented technology.
Heragen, Inc. is a spin-off from the Breast Cancer Startup Challenge conducted by National Institute of Health (NIH), National Cancer Institute (NCI), Avon Foundation and Center for Advanced Innovation (CAI).
Company Details
- Founded
- 2014
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.heragen.com
- Keywords
- Alexandria.
Heragen Questions
Heragen's website is http://www.heragen.com
Heragen's LinkedIn profile is https://www.linkedin.com/company/heragen
Heragen's industry is
Biotechnology Research
Heragen's top competitors are
Curia,
Carot Labs,
Empirico,
Yuvabharathi International School,
Mclane Company, Inc.,
Anubio,
Shrm,
Alamar Biosciences, Inc..
Heragen's categories are Biotechnology Research
Heragen's founding year is 2014
